CytoDyn (CYDY) Ending Cash Balance (2016 - 2026)
CytoDyn (CYDY) reported Ending Cash Balance of $16.36 million for fiscal Q1 2027 (quarter ended Aug 31, 2026), up 75.3% from $9.33 million a year earlier and up 38.0% from the prior quarter.
CytoDyn (CYDY) Ending Cash Balance (2016 - 2026) Analysis & Trends
For FY2026 (ended May 31, 2026), CytoDyn posted Ending Cash Balance of $11.85 million, down 0.4% from FY2025.
- Ending Cash Balance has a five-year compound annual growth rate of -19.0% (FY2021 to FY2026).
- By fiscal year, Ending Cash Balance came in at $11.9 million in FY2025 (+21.3%), $9.81 million in FY2024 (+8.5%), $9.05 million in FY2023 (+113.9%) and $4.23 million in FY2022 (-87.5%).
- The fiscal Q1 2027 figure ranks as the highest quarterly Ending Cash Balance since fiscal Q3 2025.
- Year over year, Ending Cash Balance gained in four of the last eight quarters, with growth averaging 34.3%.
- The high point for year-over-year Ending Cash Balance in five years was fiscal Q3 2023 (growth of 370.2%); the low point was fiscal Q4 2022 (a decline of 87.5%).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $11.85 million (Q4 2026), $15.66 million (Q3 2026) and $4.98 million (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 6.89 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 4.88 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 1.03 Bn |
| 10 | CytoDyn | 352.68 Mn | 303.84 Mn | - | 16.36 Mn |
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 16.36 Mn |
| May 31, 2026 | 11.85 Mn |
| Feb 28, 2026 | 15.66 Mn |
| Nov 30, 2025 | 4.98 Mn |
| Aug 31, 2025 | 9.33 Mn |
| May 31, 2025 | 11.90 Mn |
| Feb 28, 2025 | 16.40 Mn |
| Nov 30, 2024 | 21.34 Mn |
| Aug 31, 2024 | 24.92 Mn |
| May 31, 2024 | 9.81 Mn |
| Feb 29, 2024 | 8.02 Mn |
| Nov 30, 2023 | 6.72 Mn |
| Aug 31, 2023 | 8.57 Mn |
| May 31, 2023 | 9.05 Mn |
| Feb 28, 2023 | 11.11 Mn |
| Nov 30, 2022 | 2.60 Mn |
| Aug 31, 2022 | 4.68 Mn |
| May 31, 2022 | 4.23 Mn |
| Feb 28, 2022 | 2.36 Mn |
| Nov 30, 2021 | 8.88 Mn |
CytoDyn Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=CYDY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "CYDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=CYDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();